These results reinforce our conclusion that 5-Aza-CdR-induced ANO1 expression has positive impact on metastatic potential of prostate cancer cells and leads to osteolytic lesions by upregulating osteoclast differentiation at the metastatic bone lesion. The gene discussed is ANO1; the disease is prostate carcinoma.